Literature DB >> 23759514

Induction of vascular insulin resistance and endothelin-1 expression and acceleration of atherosclerosis by the overexpression of protein kinase C-β isoform in the endothelium.

Qian Li1, Kyoungmin Park, Chenzhong Li, Christian Rask-Madsen, Akira Mima, Weier Qi, Koji Mizutani, Paul Huang, George L King.   

Abstract

RATIONALE: Loss of insulin action in the endothelium can cause endothelial dysfunction and atherosclerosis. Hyperglycemia and elevated fatty acids induced by diabetes mellitus can activate protein kinase C-β isoforms and selectively inhibit insulin signaling via phosphatidylinositol 3-kinase/Akt pathway to inhibit the activation of endothelial nitric oxide synthase and metabolic actions.
OBJECTIVE: To demonstrate that overexpressing protein kinase C-β2 isoform in endothelial cells can cause selective insulin resistance and exacerbate atherosclerosis in the aorta. METHODS AND
RESULTS: Protein kinase C-β2 isoform was overexpressed in endothelial cells using a promoter of vascular endothelial cell cadherin. These mice were cross-bred with apoE-/- mice [Tg (Prkcb)apoE-/-]. On a Western diet, Tg(Prkcb)apoE-/- and apoE-/- mice did not differ in systemic insulin sensitivity, glucose tolerance, plasma lipid, or blood pressure. Insulin action in endothelial cells and femoral artery from Tg(Prkcb)apoE-/- mice was impaired by ≈40% with respect to Akt/endothelial nitric oxide synthase activation, and leukocyte-endothelial cell binding increased in cultured lung endothelial cells from Tg(Prkcb)apoE-/- mice compared with that from apoE-/- mice. Basal and angiotensin-stimulated big endothelin-1 levels were elevated in Tg(Prkcb)apoE-/- mice compared with apoE-/- mice. The severity of atherosclerosis in the aorta from Tg(Prkcb)apoE-/- mice increased by ≈70% as measured by en face fat staining and plaque content of the number of smooth muscle cells, macrophages, and extracellular matrix.
CONCLUSIONS: Specific protein kinase C-β2 activation in the endothelial cells caused dysfunction and accelerated atherosclerosis because of loss of insulin-stimulated Akt/endothelial nitric oxide synthase activation and angiotensin-induced increases in endothelin-1 expression.

Entities:  

Keywords:  atherosclerosis; endothelium; insulin resistance; protein kinase C

Mesh:

Substances:

Year:  2013        PMID: 23759514      PMCID: PMC3893704          DOI: 10.1161/CIRCRESAHA.113.301074

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  35 in total

1.  Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells.

Authors:  G Zeng; F H Nystrom; L V Ravichandran; L N Cong; M Kirby; H Mostowski; M J Quon
Journal:  Circulation       Date:  2000-04-04       Impact factor: 29.690

Review 2.  Vascular smooth muscle growth: autocrine growth mechanisms.

Authors:  B C Berk
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

3.  Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue.

Authors:  Eva Chou; Izumi Suzuma; Kerrie J Way; Darren Opland; Allen C Clermont; Keiko Naruse; Kiyoshi Suzuma; Nancy L Bowling; Chris J Vlahos; Lloyd Paul Aiello; George L King
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

Review 4.  Protein kinase C beta (PKC beta): normal functions and diseases.

Authors:  Toshiaki Kawakami; Yuko Kawakami; Jiro Kitaura
Journal:  J Biochem       Date:  2002-11       Impact factor: 3.387

5.  Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation.

Authors:  J Y Park; N Takahara; A Gabriele; E Chou; K Naruse; K Suzuma; T Yamauchi; S W Ha; M Meier; C J Rhodes; G L King
Journal:  Diabetes       Date:  2000-07       Impact factor: 9.461

6.  Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice.

Authors:  P J Kuhlencordt; R Gyurko; F Han; M Scherrer-Crosbie; T H Aretz; R Hajjar; M H Picard; P L Huang
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

7.  A major role for VCAM-1, but not ICAM-1, in early atherosclerosis.

Authors:  M I Cybulsky; K Iiyama; H Li; S Zhu; M Chen; M Iiyama; V Davis; J C Gutierrez-Ramos; P W Connelly; D S Milstone
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 8.  Regulation of smooth muscle cell accumulation in diabetes-accelerated atherosclerosis.

Authors:  B Askari; C B Renard; K E Bornfeldt
Journal:  Histol Histopathol       Date:  2002-10       Impact factor: 2.303

9.  Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes.

Authors:  Tamotsu Yokota; Ronald C Ma; Joong-Yeol Park; Keiji Isshiki; Konstantinos B Sotiropoulos; Ravi K Rauniyar; Karin E Bornfeldt; George L King
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

10.  Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation.

Authors:  T Inoguchi; R Battan; E Handler; J R Sportsman; W Heath; G L King
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

View more
  39 in total

Review 1.  New insights into insulin action and resistance in the vasculature.

Authors:  Camila Manrique; Guido Lastra; James R Sowers
Journal:  Ann N Y Acad Sci       Date:  2014-03-20       Impact factor: 5.691

Review 2.  Metabolic Regulation of Angiogenesis in Diabetes and Aging.

Authors:  Naoki Sawada; Zolt Arany
Journal:  Physiology (Bethesda)       Date:  2017-07

Review 3.  Role of oxidative stress in endothelial insulin resistance.

Authors:  Francesco Paneni; Sarah Costantino; Francesco Cosentino
Journal:  World J Diabetes       Date:  2015-03-15

4.  Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function.

Authors:  Kyoungmin Park; Qian Li; Net Daş Evcimen; Christian Rask-Madsen; Yasutaka Maeda; Ernesto Maddaloni; Hisashi Yokomizo; Takanori Shinjo; Ronald St-Louis; Jialin Fu; Daniel Gordin; Mogher Khamaisi; David Pober; Hillary Keenan; George L King
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-21       Impact factor: 8.311

Review 5.  Endothelial Cell Metabolism.

Authors:  Guy Eelen; Pauline de Zeeuw; Lucas Treps; Ulrike Harjes; Brian W Wong; Peter Carmeliet
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 6.  Disturbed Flow-Induced Endothelial Proatherogenic Signaling Via Regulating Post-Translational Modifications and Epigenetic Events.

Authors:  Kyung-Sun Heo; Bradford C Berk; Jun-Ichi Abe
Journal:  Antioxid Redox Signal       Date:  2016-04-05       Impact factor: 8.401

Review 7.  Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes.

Authors:  Manasi S Shah; Michael Brownlee
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

Review 8.  Insulin resistance, diabetes, and cardiovascular risk.

Authors:  Francesco Paneni; Sarah Costantino; Francesco Cosentino
Journal:  Curr Atheroscler Rep       Date:  2014-07       Impact factor: 5.113

9.  Evidence stacks up that endothelial insulin resistance is a culprit in atherosclerosis.

Authors:  Jenny E Kanter; Karin E Bornfeldt
Journal:  Circ Res       Date:  2013-08-02       Impact factor: 17.367

10.  Insulin decreases atherosclerosis by inducing endothelin receptor B expression.

Authors:  Kyoungmin Park; Akira Mima; Qian Li; Christian Rask-Madsen; Pingnian He; Koji Mizutani; Sayaka Katagiri; Yasutaka Maeda; I-Hsien Wu; Mogher Khamaisi; Simone Rordam Preil; Ernesto Maddaloni; Ditte Sørensen; Lars Melholt Rasmussen; Paul L Huang; George L King
Journal:  JCI Insight       Date:  2016-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.